High-content Screening Market Research Report and Forecast up to 2027 High-content Screening Market - Global Industry An | Page 2

The high-content screening market can be segmented on the basis of product,
application, end-user, and region. The product segments include cell imaging
systems, flow cytometers, microplates, software, and consumables. Increasing
preference to technologically advanced services and innovative products is a factor
expected to fuel the high-content screening market during the forecast period.
Based on application, the market has been segmented into primary and secondary
screening, target identification and validation, toxicity studies, and compound
profiling. Based on end-user, the market can be segmented into pharmaceutical
industry,
biotechnology
industry,
educational
institutions,
government
organizations, and contract research organizations (CROs).
Geographically, the high-content screening market can be segmented into North
America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North
America is estimated to hold the major share of the global high-content screening
market during the forecast period, due to presence of superior research and health
care facilities, strong regional economy, and greater focus on healthcare wellness
by the government. This trend has also reflected in other countries. The high-
content screening market in Europe is expected to witness growth at a rapid pace in
the next few years, due to high consciousness about wellbeing coupled with
increasing expenditure on R&D activities in the region. Countries in Asia Pacific such
as China, Japan, and India are also poised to be promising markets for high-content
screening in the near future. Major factors responsible for the positive outlook for
the Asia Pacific market are extensive development of health care infrastructure and
growing emphasis on research and development in the health care sector.
Key players in the global high-content screening market include Thermo Fisher
Scientific, PerkinElmer Inc., GE Healthcare, Becton, Dickinson and Company (BD),
Olympus Corporation, Thorlabs Inc., Merck KGaA, Cell Signaling Technology,
Genedata AG, and Yokogawa Electric Corporation.
The report offers a comprehensive evaluation of the market. It does so via in-depth
qualitative insights, historical data, and verifiable projections about market size. The
projections featured in the report have been derived using proven research
methodologies and assumptions. By doing so, the research report serves as a
repository of analysis and information for every facet of the market, including but
not limited to: Regional markets, technology, types, and applications.
Get accurate market forecast and analysis on the Bleeding Disorder
Treatment market. Request a sample to stay abreast on the key trends
impacting this market.
http://www.transparencymarketresearch.com/sa mple/sample.php?
flag=B&rep_id=23777
The study is a source of reliable data on: